Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 22

1.

Molecular targeting of ultrasonographic contrast agent for detection of head and neck squamous cell carcinoma.

Knowles JA, Heath CH, Saini R, Umphrey H, Warram J, Hoyt K, Rosenthal EL.

Arch Otolaryngol Head Neck Surg. 2012 Jul;138(7):662-8. doi: 10.1001/archoto.2012.1081.

2.

Systemic delivery of a breast cancer-detecting adenovirus using targeted microbubbles.

Warram JM, Sorace AG, Saini R, Borovjagin AV, Hoyt K, Zinn KR.

Cancer Gene Ther. 2012 Aug;19(8):545-52. doi: 10.1038/cgt.2012.29. Epub 2012 Jun 1.

3.

A triple-targeted ultrasound contrast agent provides improved localization to tumor vasculature.

Warram JM, Sorace AG, Saini R, Umphrey HR, Zinn KR, Hoyt K.

J Ultrasound Med. 2011 Jul;30(7):921-31.

4.

Model system using controlled receptor expression for evaluating targeted ultrasound contrast agents.

Saini R, Warram JM, Sorace AG, Umphrey H, Zinn KR, Hoyt K.

Ultrasound Med Biol. 2011 Aug;37(8):1306-13. doi: 10.1016/j.ultrasmedbio.2011.05.010. Epub 2011 Jun 16.

5.

Molecular and functional ultrasound imaging in differently aggressive breast cancer xenografts using two novel ultrasound contrast agents (BR55 and BR38).

Bzyl J, Lederle W, Rix A, Grouls C, Tardy I, Pochon S, Siepmann M, Penzkofer T, Schneider M, Kiessling F, Palmowski M.

Eur Radiol. 2011 Sep;21(9):1988-95. doi: 10.1007/s00330-011-2138-y. Epub 2011 May 12.

PMID:
21562807
6.

Targeted contrast-enhanced ultrasound: an emerging technology in abdominal and pelvic imaging.

Pysz MA, Willmann JK.

Gastroenterology. 2011 Mar;140(3):785-90. doi: 10.1053/j.gastro.2011.01.027. Epub 2011 Jan 18. Review. No abstract available.

7.

Molecular imaging: current status and emerging strategies.

Pysz MA, Gambhir SS, Willmann JK.

Clin Radiol. 2010 Jul;65(7):500-16. doi: 10.1016/j.crad.2010.03.011. Review.

8.

Antiangiogenic cancer therapy: monitoring with molecular US and a clinically translatable contrast agent (BR55).

Pysz MA, Foygel K, Rosenberg J, Gambhir SS, Schneider M, Willmann JK.

Radiology. 2010 Aug;256(2):519-27. doi: 10.1148/radiol.10091858. Epub 2010 Jun 1.

9.

Targeted contrast-enhanced ultrasound imaging of tumor angiogenesis with contrast microbubbles conjugated to integrin-binding knottin peptides.

Willmann JK, Kimura RH, Deshpande N, Lutz AM, Cochran JR, Gambhir SS.

J Nucl Med. 2010 Mar;51(3):433-40. doi: 10.2967/jnumed.109.068007. Epub 2010 Feb 11.

10.

BR55: a lipopeptide-based VEGFR2-targeted ultrasound contrast agent for molecular imaging of angiogenesis.

Pochon S, Tardy I, Bussat P, Bettinger T, Brochot J, von Wronski M, Passantino L, Schneider M.

Invest Radiol. 2010 Feb;45(2):89-95. doi: 10.1097/RLI.0b013e3181c5927c.

PMID:
20027118
11.

Molecular imaging of the initial inflammatory response in atherosclerosis: implications for early detection of disease.

Kaufmann BA, Carr CL, Belcik JT, Xie A, Yue Q, Chadderdon S, Caplan ES, Khangura J, Bullens S, Bunting S, Lindner JR.

Arterioscler Thromb Vasc Biol. 2010 Jan;30(1):54-9. doi: 10.1161/ATVBAHA.109.196386. Epub 2009 Oct 15.

12.

Dual targeting improves microbubble contrast agent adhesion to VCAM-1 and P-selectin under flow.

Ferrante EA, Pickard JE, Rychak J, Klibanov A, Ley K.

J Control Release. 2009 Dec 3;140(2):100-7. doi: 10.1016/j.jconrel.2009.08.001. Epub 2009 Aug 8.

13.

Ultrasound molecular imaging of atherosclerosis.

Kaufmann BA.

Cardiovasc Res. 2009 Sep 1;83(4):617-25. doi: 10.1093/cvr/cvp179. Epub 2009 Jun 3. Review.

PMID:
19493955
14.

US imaging of tumor angiogenesis with microbubbles targeted to vascular endothelial growth factor receptor type 2 in mice.

Willmann JK, Paulmurugan R, Chen K, Gheysens O, Rodriguez-Porcel M, Lutz AM, Chen IY, Chen X, Gambhir SS.

Radiology. 2008 Feb;246(2):508-18. doi: 10.1148/radiol.2462070536. Epub 2008 Jan 7.

15.

Monitoring response to anticancer therapy by targeting microbubbles to tumor vasculature.

Korpanty G, Carbon JG, Grayburn PA, Fleming JB, Brekken RA.

Clin Cancer Res. 2007 Jan 1;13(1):323-30.

16.

Prolonging the ultrasound signal enhancement from thrombi using targeted microbubbles based on sulfur-hexafluoride-filled gas.

Wang B, Zang WJ, Wang M, Ai H, Wang YW, Li YP, He GS, Wang L, Yu XJ.

Acad Radiol. 2006 Apr;13(4):428-33.

PMID:
16554222
17.

Targeting mucosal addressin cellular adhesion molecule (MAdCAM)-1 to noninvasively image experimental Crohn's disease.

Bachmann C, Klibanov AL, Olson TS, Sonnenschein JR, Rivera-Nieves J, Cominelli F, Ley KF, Lindner JR, Pizarro TT.

Gastroenterology. 2006 Jan;130(1):8-16.

PMID:
16401463
18.

Ultrasonic imaging of tumor angiogenesis using contrast microbubbles targeted via the tumor-binding peptide arginine-arginine-leucine.

Weller GE, Wong MK, Modzelewski RA, Lu E, Klibanov AL, Wagner WR, Villanueva FS.

Cancer Res. 2005 Jan 15;65(2):533-9.

19.

Ligand-carrying gas-filled microbubbles: ultrasound contrast agents for targeted molecular imaging.

Klibanov AL.

Bioconjug Chem. 2005 Jan-Feb;16(1):9-17. Review. No abstract available.

PMID:
15656569
20.

Non-invasive gamma camera imaging of gene transfer using an adenoviral vector encoding an epitope-tagged receptor as a reporter.

Rogers BE, Chaudhuri TR, Reynolds PN, Della Manna D, Zinn KR.

Gene Ther. 2003 Jan;10(2):105-14.

PMID:
12571639

Supplemental Content

Support Center